Closed-loop stimulation is a breakthrough that has great potential for helping patients manage their pain.
Pain interventions can lessen cancer-causing pain and often lead to a reduction in opioid prescriptions. A Pain Management specialist highlights the intrathecal pump and other interventions.
Findings of this milestone investigation suggest that analgesia may not be the appropriate therapy goal in central pain syndromes and that neuromodulation should focus on pain-related suffering and disability.
Although fibromyalgia has no anatomic lesions, it’s marked by neurological dysfunction — qualifying it as a neuropathic disorder. Linking it to central sensitization can increase the array of treatment options.
Cleveland Clinic is a non-profit academic medical center. Advertising on our site helps support our mission. We do not endorse non-Cleveland Clinic products or services Policy
Promising research at Cleveland Clinic shows that microglial inflammation is a common, and potentially treatable, pathway for neuropathic pain and other treatment-resistant neuroinflammatory conditions, including Alzheimer disease.